Global Coronary Atherectomy Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices, Rotational Atherectomy Devices, and Others.

By Application;

Peripheral Vascular, Cardiovascular, and Neurovascular.

By End User;

Hospitals And Surgical Centers, Ambulatory Care Centers, and Research Laboratories, And Academic Institutes.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn155240534 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Coronary Atherectomy Devices Market (USD Million), 2021 - 2031

In the year 2024, the Global Coronary Atherectomy Devices Market was valued at USD 233.59 million. The size of this market is expected to increase to USD 476.16 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 10.7%.

The global coronary atherectomy devices market is a critical component of the cardiovascular medical device industry, driven by the increasing prevalence of coronary artery disease (CAD) and advancements in minimally invasive surgical technologies. Coronary artery disease is one of the leading causes of death worldwide, with millions of people affected by blocked or narrowed coronary arteries. Atherectomy devices, which are used to remove atherosclerotic plaque from the arteries, play a crucial role in improving blood flow and preventing further complications associated with CAD, including heart attacks and strokes. These devices are used in conjunction with other interventional cardiology procedures, such as angioplasty and stenting, to treat complex lesions that are difficult to address with traditional balloon angioplasty alone. The growing awareness of CAD, along with the rising aging population and an increase in risk factors such as hypertension, diabetes, smoking, and obesity, has led to a surge in demand for effective treatments like coronary atherectomy. As a result, the coronary atherectomy devices market is experiencing substantial growth.

Atherectomy devices can be categorized into several types, including directional atherectomy devices, orbital atherectomy devices, photo-ablation atherectomy devices, rotational atherectomy devices, and others, each catering to specific clinical needs. Directional atherectomy devices are widely used for their ability to remove plaque in a controlled direction, providing a safe and effective way to address coronary blockages. Orbital atherectomy devices use high-speed rotational motion to help break down plaque, particularly in cases of calcified lesions that may be more resistant to other treatments. Photo-ablation atherectomy devices utilize laser technology to vaporize and remove plaque, offering precision in delicate areas. Rotational atherectomy devices are used for high-speed plaque removal, particularly in patients with more hardened or calcified arterial blockages. The advancements in these technologies have significantly improved the ability to treat complex coronary lesions, reduce the risk of restenosis (re-narrowing of the artery), and enhance long-term patient outcomes. As the demand for minimally invasive treatments increases, these devices offer patients an option for safer and less invasive procedures compared to traditional open-heart surgery.

One of the primary drivers of market growth is the rising global prevalence of cardiovascular diseases and the increasing number of coronary artery interventions performed annually. Coronary interventions, including the use of atherectomy devices, are crucial for managing a growing number of patients suffering from CAD, especially as the global population ages. Additionally, advancements in medical technologies have led to more efficient and user-friendly atherectomy devices, which are easier to use and provide better precision in plaque removal. This has further fueled the adoption of atherectomy devices in hospitals, specialty clinics, ambulatory surgical centers, and diagnostic laboratories. Furthermore, these devices play a vital role in addressing complex cases of coronary artery disease, such as those involving heavily calcified lesions or challenging arterial anatomies, where traditional balloon angioplasty or stenting may be less effective.

Another factor contributing to the market’s growth is the shift toward minimally invasive procedures. Atherectomy procedures offer a less invasive alternative to traditional coronary artery bypass graft (CABG) surgery, leading to shorter recovery times, fewer complications, and reduced hospital stays. This trend is particularly important as healthcare systems worldwide seek to reduce costs while improving patient outcomes. Moreover, the increase in outpatient procedures, especially in ambulatory surgical centers, has enhanced the accessibility of these advanced treatment options. As a result, coronary atherectomy devices are being increasingly used in various healthcare settings, contributing to the overall expansion of the market. In parallel, ongoing research and development efforts continue to enhance the efficacy, safety, and versatility of these devices, ensuring that coronary atherectomy remains a key option in the treatment of coronary artery disease. With the growing demand for effective, minimally invasive treatments and continuous innovation in device technology, the global coronary atherectomy devices market is poised for sustained growth in the coming years.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Application
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Global Coronary Atherectomy Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Prevalence of Cardiovascular Diseases (CVDs)
        2. Technological Advancements
        3. Favorable Reimbursement Scenario
      2. Restraints
        1. Stringent Regulatory Framework
        2. High Cost of Procedures
        3. Limited Availability of Trained Specialists
      3. Opportunities
        1. Development of New Technologies
        2. Focus on Minimally Invasive Procedures
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Global Coronary Atherectomy Devices Market, By Product, 2021 - 2031 (USD Million)
      1. Directional Atherectomy Devices
      2. Orbital Atherectomy Devices
      3. Photo-Ablative Atherectomy Devices
      4. Rotational Atherectomy Devices
      5. Others
    2. Global Coronary Atherectomy Devices Market, By Applicaton, 2021 - 2031 (USD Million)
      1. Peripheral Vascular
      2. Cardiovascular
      3. Neurovascular
    3. Global Coronary Atherectomy Devices Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals And Surgical Centers
      2. Ambulatory Care Centers
      3. Research Laboratories And Academic Institutes.
    4. Global Coronary Atherectomy Devices Market, By Geography, 2021- 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Boston Scientific
      2. Philips
      3. Cardiovascular Systems
      4. Spectranetics
      5. Medtronic
  7. Analyst Views
  8. Future Outlook of the Market